Skip to main content

Table 3 Ranking variables of treatment choices

From: The families evaluation on management, care and disclosure for terminal stage cancer patients

  Expectance of survival Expected Effectiveness Complications Side-effects Consequences in sexuality Patient's Choice Short term QoL Long term QoL
Choices        
1st 41 (28%) 24(16%) 4 (3%) 0 18(12%) 8 (5.5%) 27(18.5%)
2nd 20 (14%) 41 (28%) 5 (3%) 0 11(7.5%) 20(13.5%) 27(18.5%)
3rd 20 (14%) 27(18.5%) 17(12%) 0 18(12%) 12 (8%) 28 (19%)
4th 23 (16%) 12 (8%) 26(18%) 4 (3%) 17(11.5%) 31 (21%) 11(7.5%)
5th 5 (3%) 17(11.5%) 30 (20.5%) 2 (1%) 24(16%) 28(19%) 17(11.5%)
6th 12 (8%) 2 (1%) 34 (23%) 26(18%) 28(19%) 14 (9.5%) 7 (5%)
7th 3 (2%) 0 6 (4%) 92 (63%) 8 (5.5%) 11 (7.5%) 4 (3%)
missing 22 (15%) 22(15%) 22(15%) 22 (15%) 22(15%) 22(15%) 22(15%)